N-acetyl-L-tyrosine is sold as the upgraded, more bioavailable form of tyrosine, interchangeable with the plain amino acid but better. The pharmacology says otherwise, and this piece lays out why. Its one real advantage, solubility, is why it was developed for intravenous nutrition, but multiple human studies show the body deacetylates it poorly and excretes a large fraction unchanged in urine, so it raises tyrosine far less effectively than plain L-tyrosine. It also flags the species trap behind the marketing, since rats handle it well and humans do not, and notes that every cognitive study worth citing used the plain form. A clean case of a bioavailability claim the evidence contradicts.

Citicoline is usually sold as a choline source for acetylcholine, but its more distinctive role is feeding the pathway that builds and repairs neuronal cell membranes. This piece explains that connection properly: why membranes are the substance of synapses, how the Kennedy pathway makes phosphatidylcholine, and why citicoline is literally the intermediate at the center of it. It covers the membrane breakdown seen in stroke and Alzheimer's, the precursor-combination research, and the human spectroscopy studies that show real effects on brain chemistry. It is candid throughout about the crucial gap between an elegant, well-documented mechanism and a proven benefit for a healthy brain.

Almost every supplement that promises sharper focus or better memory is aimed, in the end, at a single neurotransmitter: acetylcholine. This piece explains what it actually does, from the basal-forebrain hub that supplies the cortex and hippocampus, to the fast and slow receptor systems, to its distinct roles in flagging what deserves attention and in switching the brain into a learning state. It draws on the scopolamine memory model and the cholinergic hypothesis of Alzheimer's to show why the system matters so much. It also sets up the crucial caveat behind every choline supplement: acetylcholine is produced by a tightly self-regulating system, not a tank you can simply top up.

Take a memory supplement for a few days, feel nothing, conclude it does not work: the reasoning is common and it is a category error. The trials behind Bacopa, Lion's Mane, and citicoline almost never test a single dose; they run for eight, twelve, or sixteen weeks, because the biology they target changes over weeks, not hours. This piece explains why, walking through the slow timescales of synaptic consolidation, the weeks it takes new neurons to mature, the gradual build of trophic support, and the months membranes take to remodel. It closes with the practical upshot: give real memory supplements a fair 8 to 12 week trial, and distrust anything promising overnight results.

Phosphatidylserine is a real building block of brain cell membranes, and it once produced some of the most encouraging memory-trial results in the supplement field. There is a catch that most marketing skips: those early wins used phosphatidylserine derived from cow brain, a source no longer sold, and the soy-derived version people buy today has produced weaker and more mixed results, including a clear null in the best-matched trial. This piece explains what phosphatidylserine does in neurons, why membrane composition matters, and why the source of the supplement changes what the evidence can claim. It ends with the unusually candid verdict from the FDA itself.